Concepedia
Statistics
Publications
3
Citations
440
H-Index
Active since
2004
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Joëlle Rudloff is an author at Novartis (Switzerland) specializing in oncology, pharmacology, and mtor inhibition.
Publications per year
2004–2009
Dual Inhibition of mTOR and Estrogen Receptor Signaling<i>In vitro</i>Induces Cell Death in Models of Breast Cancer
Anne Boulay, Joëlle Rudloff, Jingjing Ye et al. · Clinical Cancer Research · 2005 · 335 citations · Full text
Medicine, Oncology, Pharmacology +17
Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue
Patrick Chêne, Joëlle Rudloff, Joseph Schoepfer et al. · BMC Chemical Biology · 2009 · 81 citations · Full text
Medicine, Oncology, Pharmacology +15
The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma
Joëlle Rudloff, Anne Boulay, Sabine Zumstein-Mecker et al. · Cancer Research · 2004 · 24 citations
Life Sciences, Oncology, Pharmacology +17
1–3 of 3